CRISPR Therapeutics AG (CRSP) Insider Trading

Name: CRISPR Therapeutics AG (CRSP) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 8, 2026): James R. Kasinger (General Counsel and Secretary): Exercise/Conversion of 1,990 shares, $27.1K.

Get alerted when insiders trade CRSP

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta